The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline today and set a price target of £13.97. The company’s shares opened today at p1,424.50. Take advantage of TipRanks Premium ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on GlaxoSmithKline. The company’s shares closed yesterday at $37.67. Take advantage of TipRanks Premium at 50% off!

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

The FTSE 100 began Friday’s session on a positive note, gaining 23 points, reaching 9,124, as investors paid attention to ...

Hengrui Pharma partners with GSK to develop 12 innovative medicines, boosting globalization for Hengrui and expanding GSK's oncology and RI&I pipeline.

LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported second-quarter earnings of $1.93 billion. The London-based company said it had profit of 94 cents per share. Earnings, adjusted for ...

Glaxosmithkline Share Chat. Chat About GSK Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.